$1.5 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 52.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KAR | Sell | KAR AUCTION SVCS INC | $76,381,000 | -8.2% | 2,013,726 | -16.1% | 5.10% | -2.5% |
| MDCO | Sell | MEDICINES CO | $54,727,000 | -36.8% | 1,953,133 | -37.6% | 3.66% | -32.9% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Dcl a new | $39,476,000 | -15.5% | 204,423 | -27.1% | 2.64% | -10.3% |
| HCA | Sell | HCA HOLDINGS INC | $34,671,000 | -34.4% | 460,862 | -36.0% | 2.32% | -30.3% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $25,341,000 | -70.3% | 406,756 | -72.6% | 1.69% | -68.5% |
| VRSN | Sell | VERISIGN INC | $21,545,000 | -37.5% | 321,709 | -46.8% | 1.44% | -33.7% |
| T107PS | Sell | WRIGHT MED GROUP INC | $13,768,000 | -31.2% | 533,638 | -28.3% | 0.92% | -26.9% |
| CWST | Sell | CASELLA WASTE SYS INCcl a | $2,993,000 | +33.3% | 544,220 | -2.1% | 0.20% | +41.8% |
| P | Exit | PANDORA MEDIA INC | $0 | – | -1,019,726 | -100.0% | -1.14% | – |
| HYH | Exit | HALYARD HEALTH INC | $0 | – | -413,662 | -100.0% | -1.18% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -124,250 | -100.0% | -1.66% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -711,232 | -100.0% | -1.83% | – |
| PCLN | Exit | PRICELINE GRP INC | $0 | – | -38,000 | -100.0% | -2.73% | – |
| ECOM | Exit | CHANNELADVISOR CORP | $0 | – | -2,170,993 | -100.0% | -2.95% | – |
| GM | Exit | GENERAL MTRS CO | $0 | – | -1,401,965 | -100.0% | -3.08% | – |
| PNK | Exit | PINNACLE ENTMT INC | $0 | – | -2,272,492 | -100.0% | -3.18% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -1,747,533 | -100.0% | -3.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.